CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report sent to investors on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $10.00 target price on shares of CASI Pharmaceuticals in a research report […]

Related Keywords

United States ,Wellington ,New Zealand General ,New Zealand , ,Citigroup Inc ,Pharmaceuticals Daily ,Susquehanna International Group ,Virtu Financial ,Pharmaceuticals Trading Down ,Renaissance Technologies ,Pharmaceuticals Inc ,Wellington Shields Co ,Free Report ,Trading Down ,Get Free Report ,International Group ,Wellington Shields ,Casi Pharmaceuticals ,Nasdaq Casi ,Casi ,Medical ,Initiated Coverage ,Stocknews Com ,